The Global Carrier Screening Market is Estimated to reach $2,501.94 Million by 2027, at a CAGR of 10.81%

Carrier Screening Market Growth, Trends and Report Highlights

According to a new report Global Carrier Screening Market, published by KBV research, The Global Carrier Screening Market size is expected to reach $2,501.94 million by 2027, rising at a market growth of 10.81% CAGR during the forecast period.

The Expanded Carrier Screening market dominated the Europe Carrier Screening Market by Type in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $449.4 million by 2027, growing at a CAGR of 10.7 % during the forecast period.

The North America market dominated the Global Carrier Screening Market by Region in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $1,095.1 million by 2027. The Europe market is expected to witness a CAGR of 11% during (2021 - 2027). Additionally, The Asia Pacific market is expected to witness a CAGR of 12.9% during (2021 - 2027).

Full Report: https://www.kbvresearch.com/carrier-screening-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Quest Diagnostics, Incorporated, Thermo Fisher Scientific, Illumina, Inc., Eurofins Scientific Group, Invitae Corporation, OPKO Health, Inc., Fulgent Genetics, Sema4 OpCo, Inc., Myriad Genetics, Inc., and Natera, Inc.

Global Carrier Screening Market Segmentation

By Type

• Expanded Carrier Screening and
• Targeted Disease Carrier Screening

By Technology

• DNA Sequencing
• Microarrays
• Polymerase Chain Reaction and
• Other technology

By End User

• Hospital and Clinics
• Physician Offices
• Reference Laboratories and
• Other End Users

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Quest Diagnostics, Incorporated
• Thermo Fisher Scientific
• Illumina, Inc.
• Eurofins Scientific Group
• Invitae Corporation
• OPKO Health, Inc.
• Fulgent Genetics
• Sema4 OpCo, Inc.
• Myriad Genetics, Inc.
• Natera, Inc.

Unique Offerings from KBV Research

• Exhaustive coverage
• The highest number of market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Related Reports:

North America Carrier Screening Market, Future Scope & Opportunities 2021-2027

Europe Carrier Screening Market, Size & Growth Forecast 2021-2027

Asia Pacific Carrier Screening Market, Size, Share & Industry Outlook to 2027

LAMEA Carrier Screening Market, Growth, Trends and Forecasts 2021-2027